Global Drug Concentration Detection Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Drug Concentration Detection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Concentration Detection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Drug Concentration Detection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Drug Concentration Detection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Drug Concentration Detection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Drug Concentration Detection include Thermo Fisher Scientific, Abbott, ACROBiosystems, bioMerieux, Bio-Rad Laboratories, Bühlmann Laboratories, Danaher, Randox Laboratories and Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Concentration Detection, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Drug Concentration Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Concentration Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Concentration Detection revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Drug Concentration Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Drug Concentration Detection revenue, projected growth trends, production technology, application and end-user industry.


Drug Concentration Detection Segment by Company

Thermo Fisher Scientific
Abbott
ACROBiosystems
bioMerieux
Bio-Rad Laboratories
Bühlmann Laboratories
Danaher
Randox Laboratories
Roche
Sekisui Medical
Siemens Healthineers
Shanghai Genext Medical Technology
Beijing Chromai
Beijing IPHASE
Beijing Diagreat
Beijing Haosi Biotech

Drug Concentration Detection Segment by Type

Blood Detection
Urine Detection
Others

Drug Concentration Detection Segment by Application

Hospital
Clinic
Others

Drug Concentration Detection Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Concentration Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Concentration Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Concentration Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Drug Concentration Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Drug Concentration Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Concentration Detection revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Drug Concentration Detection Market by Type
1.2.1 Global Drug Concentration Detection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Blood Detection
1.2.3 Urine Detection
1.2.4 Others
1.3 Drug Concentration Detection Market by Application
1.3.1 Global Drug Concentration Detection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Drug Concentration Detection Market Dynamics
2.1 Drug Concentration Detection Industry Trends
2.2 Drug Concentration Detection Industry Drivers
2.3 Drug Concentration Detection Industry Opportunities and Challenges
2.4 Drug Concentration Detection Industry Restraints
3 Global Growth Perspective
3.1 Global Drug Concentration Detection Market Perspective (2020-2031)
3.2 Global Drug Concentration Detection Growth Trends by Region
3.2.1 Global Drug Concentration Detection Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Drug Concentration Detection Market Size by Region (2020-2025)
3.2.3 Global Drug Concentration Detection Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Drug Concentration Detection Revenue by Players
4.1.1 Global Drug Concentration Detection Revenue by Players (2020-2025)
4.1.2 Global Drug Concentration Detection Revenue Market Share by Players (2020-2025)
4.1.3 Global Drug Concentration Detection Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Drug Concentration Detection Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Drug Concentration Detection Key Players Headquarters & Area Served
4.4 Global Drug Concentration Detection Players, Product Type & Application
4.5 Global Drug Concentration Detection Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Drug Concentration Detection Market CR5 and HHI
4.6.3 2024 Drug Concentration Detection Tier 1, Tier 2, and Tier 3
5 Drug Concentration Detection Market Size by Type
5.1 Global Drug Concentration Detection Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Drug Concentration Detection Revenue by Type (2020-2031)
5.3 Global Drug Concentration Detection Revenue Market Share by Type (2020-2031)
6 Drug Concentration Detection Market Size by Application
6.1 Global Drug Concentration Detection Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Drug Concentration Detection Revenue by Application (2020-2031)
6.3 Global Drug Concentration Detection Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Comapny Information
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Scientific Drug Concentration Detection Product Portfolio
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Abbott
7.2.1 Abbott Comapny Information
7.2.2 Abbott Business Overview
7.2.3 Abbott Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.2.4 Abbott Drug Concentration Detection Product Portfolio
7.2.5 Abbott Recent Developments
7.3 ACROBiosystems
7.3.1 ACROBiosystems Comapny Information
7.3.2 ACROBiosystems Business Overview
7.3.3 ACROBiosystems Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.3.4 ACROBiosystems Drug Concentration Detection Product Portfolio
7.3.5 ACROBiosystems Recent Developments
7.4 bioMerieux
7.4.1 bioMerieux Comapny Information
7.4.2 bioMerieux Business Overview
7.4.3 bioMerieux Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.4.4 bioMerieux Drug Concentration Detection Product Portfolio
7.4.5 bioMerieux Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Comapny Information
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.5.4 Bio-Rad Laboratories Drug Concentration Detection Product Portfolio
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 Bühlmann Laboratories
7.6.1 Bühlmann Laboratories Comapny Information
7.6.2 Bühlmann Laboratories Business Overview
7.6.3 Bühlmann Laboratories Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.6.4 Bühlmann Laboratories Drug Concentration Detection Product Portfolio
7.6.5 Bühlmann Laboratories Recent Developments
7.7 Danaher
7.7.1 Danaher Comapny Information
7.7.2 Danaher Business Overview
7.7.3 Danaher Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.7.4 Danaher Drug Concentration Detection Product Portfolio
7.7.5 Danaher Recent Developments
7.8 Randox Laboratories
7.8.1 Randox Laboratories Comapny Information
7.8.2 Randox Laboratories Business Overview
7.8.3 Randox Laboratories Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.8.4 Randox Laboratories Drug Concentration Detection Product Portfolio
7.8.5 Randox Laboratories Recent Developments
7.9 Roche
7.9.1 Roche Comapny Information
7.9.2 Roche Business Overview
7.9.3 Roche Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.9.4 Roche Drug Concentration Detection Product Portfolio
7.9.5 Roche Recent Developments
7.10 Sekisui Medical
7.10.1 Sekisui Medical Comapny Information
7.10.2 Sekisui Medical Business Overview
7.10.3 Sekisui Medical Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.10.4 Sekisui Medical Drug Concentration Detection Product Portfolio
7.10.5 Sekisui Medical Recent Developments
7.11 Siemens Healthineers
7.11.1 Siemens Healthineers Comapny Information
7.11.2 Siemens Healthineers Business Overview
7.11.3 Siemens Healthineers Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.11.4 Siemens Healthineers Drug Concentration Detection Product Portfolio
7.11.5 Siemens Healthineers Recent Developments
7.12 Shanghai Genext Medical Technology
7.12.1 Shanghai Genext Medical Technology Comapny Information
7.12.2 Shanghai Genext Medical Technology Business Overview
7.12.3 Shanghai Genext Medical Technology Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.12.4 Shanghai Genext Medical Technology Drug Concentration Detection Product Portfolio
7.12.5 Shanghai Genext Medical Technology Recent Developments
7.13 Beijing Chromai
7.13.1 Beijing Chromai Comapny Information
7.13.2 Beijing Chromai Business Overview
7.13.3 Beijing Chromai Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.13.4 Beijing Chromai Drug Concentration Detection Product Portfolio
7.13.5 Beijing Chromai Recent Developments
7.14 Beijing IPHASE
7.14.1 Beijing IPHASE Comapny Information
7.14.2 Beijing IPHASE Business Overview
7.14.3 Beijing IPHASE Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.14.4 Beijing IPHASE Drug Concentration Detection Product Portfolio
7.14.5 Beijing IPHASE Recent Developments
7.15 Beijing Diagreat
7.15.1 Beijing Diagreat Comapny Information
7.15.2 Beijing Diagreat Business Overview
7.15.3 Beijing Diagreat Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.15.4 Beijing Diagreat Drug Concentration Detection Product Portfolio
7.15.5 Beijing Diagreat Recent Developments
7.16 Beijing Haosi Biotech
7.16.1 Beijing Haosi Biotech Comapny Information
7.16.2 Beijing Haosi Biotech Business Overview
7.16.3 Beijing Haosi Biotech Drug Concentration Detection Revenue and Gross Margin (2020-2025)
7.16.4 Beijing Haosi Biotech Drug Concentration Detection Product Portfolio
7.16.5 Beijing Haosi Biotech Recent Developments
8 North America
8.1 North America Drug Concentration Detection Revenue (2020-2031)
8.2 North America Drug Concentration Detection Revenue by Type (2020-2031)
8.2.1 North America Drug Concentration Detection Revenue by Type (2020-2025)
8.2.2 North America Drug Concentration Detection Revenue by Type (2026-2031)
8.3 North America Drug Concentration Detection Revenue Share by Type (2020-2031)
8.4 North America Drug Concentration Detection Revenue by Application (2020-2031)
8.4.1 North America Drug Concentration Detection Revenue by Application (2020-2025)
8.4.2 North America Drug Concentration Detection Revenue by Application (2026-2031)
8.5 North America Drug Concentration Detection Revenue Share by Application (2020-2031)
8.6 North America Drug Concentration Detection Revenue by Country
8.6.1 North America Drug Concentration Detection Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Drug Concentration Detection Revenue by Country (2020-2025)
8.6.3 North America Drug Concentration Detection Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Drug Concentration Detection Revenue (2020-2031)
9.2 Europe Drug Concentration Detection Revenue by Type (2020-2031)
9.2.1 Europe Drug Concentration Detection Revenue by Type (2020-2025)
9.2.2 Europe Drug Concentration Detection Revenue by Type (2026-2031)
9.3 Europe Drug Concentration Detection Revenue Share by Type (2020-2031)
9.4 Europe Drug Concentration Detection Revenue by Application (2020-2031)
9.4.1 Europe Drug Concentration Detection Revenue by Application (2020-2025)
9.4.2 Europe Drug Concentration Detection Revenue by Application (2026-2031)
9.5 Europe Drug Concentration Detection Revenue Share by Application (2020-2031)
9.6 Europe Drug Concentration Detection Revenue by Country
9.6.1 Europe Drug Concentration Detection Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Drug Concentration Detection Revenue by Country (2020-2025)
9.6.3 Europe Drug Concentration Detection Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Drug Concentration Detection Revenue (2020-2031)
10.2 China Drug Concentration Detection Revenue by Type (2020-2031)
10.2.1 China Drug Concentration Detection Revenue by Type (2020-2025)
10.2.2 China Drug Concentration Detection Revenue by Type (2026-2031)
10.3 China Drug Concentration Detection Revenue Share by Type (2020-2031)
10.4 China Drug Concentration Detection Revenue by Application (2020-2031)
10.4.1 China Drug Concentration Detection Revenue by Application (2020-2025)
10.4.2 China Drug Concentration Detection Revenue by Application (2026-2031)
10.5 China Drug Concentration Detection Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Drug Concentration Detection Revenue (2020-2031)
11.2 Asia Drug Concentration Detection Revenue by Type (2020-2031)
11.2.1 Asia Drug Concentration Detection Revenue by Type (2020-2025)
11.2.2 Asia Drug Concentration Detection Revenue by Type (2026-2031)
11.3 Asia Drug Concentration Detection Revenue Share by Type (2020-2031)
11.4 Asia Drug Concentration Detection Revenue by Application (2020-2031)
11.4.1 Asia Drug Concentration Detection Revenue by Application (2020-2025)
11.4.2 Asia Drug Concentration Detection Revenue by Application (2026-2031)
11.5 Asia Drug Concentration Detection Revenue Share by Application (2020-2031)
11.6 Asia Drug Concentration Detection Revenue by Country
11.6.1 Asia Drug Concentration Detection Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Drug Concentration Detection Revenue by Country (2020-2025)
11.6.3 Asia Drug Concentration Detection Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Drug Concentration Detection Revenue (2020-2031)
12.2 SAMEA Drug Concentration Detection Revenue by Type (2020-2031)
12.2.1 SAMEA Drug Concentration Detection Revenue by Type (2020-2025)
12.2.2 SAMEA Drug Concentration Detection Revenue by Type (2026-2031)
12.3 SAMEA Drug Concentration Detection Revenue Share by Type (2020-2031)
12.4 SAMEA Drug Concentration Detection Revenue by Application (2020-2031)
12.4.1 SAMEA Drug Concentration Detection Revenue by Application (2020-2025)
12.4.2 SAMEA Drug Concentration Detection Revenue by Application (2026-2031)
12.5 SAMEA Drug Concentration Detection Revenue Share by Application (2020-2031)
12.6 SAMEA Drug Concentration Detection Revenue by Country
12.6.1 SAMEA Drug Concentration Detection Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Drug Concentration Detection Revenue by Country (2020-2025)
12.6.3 SAMEA Drug Concentration Detection Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings